| Followers | 15 |
| Posts | 4014 |
| Boards Moderated | 1 |
| Alias Born | 07/07/2002 |
Monday, February 04, 2019 7:16:15 PM
http://retinatoday.com/2016/08/the-burden-of-noninfectious-uveitis-of-the-posterior-segment-a-review/
https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2551695
Recent EYPT News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:31:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 08:12:55 PM
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/16/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:32:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2026 09:06:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:02:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 12:05:26 PM
- EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments • GlobeNewswire Inc. • 03/04/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 12:05:30 PM
- EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema • GlobeNewswire Inc. • 03/02/2026 12:00:00 PM
- EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026 • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/24/2026 09:00:49 PM
- EyePoint Announces Participation at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:07:08 PM
- EyePoint Appoints Michael Campbell as Chief Commercial Officer • GlobeNewswire Inc. • 02/18/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:25:24 PM
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/17/2026 12:00:00 PM
- EyePoint to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 • GlobeNewswire Inc. • 02/05/2026 12:00:00 PM
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/16/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 09:13:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 09:12:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 09:12:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 09:07:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 12:05:26 PM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
